Eton Pharmaceutcials
ETON
32 hedge funds and large institutions have $24.1M invested in Eton Pharmaceutcials in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.
107% more call options, than puts
Call options by funds: $444K | Put options by funds: $215K
0.95% less ownership
Funds ownership: 24.24% → 23.29% (-0.95%)
14% less funds holding
Funds holding: 37 → 32 (-5)
18% less capital invested
Capital invested by funds: $29.5M → $24.1M (-$5.45M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
+$2.15M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$492K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$441K |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$430K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.36M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$478K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$203K |
| 4 |
HF
HRT Financial
New York
|
-$196K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$146K |
ETON Hedge Fund Activity: Q4 2021 in Review
32 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q4 2021, worth a combined $24.1M — down 18% from $29.5M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ETON and 6 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Roumell Asset Management, opening a new position worth an estimated $2.15M. The largest seller was Opaleye Management, cutting an estimated $3.36M.
- 32 institutional investors held Eton Pharmaceutcials (ETON) as of Q4 2021, down from 37 in Q3 2021.
- Funds reported $24.1M of Eton Pharmaceutcials stock for Q4 2021, down 18% quarter-over-quarter.
- 6 funds opened new Eton Pharmaceutcials positions in Q4 2021 and 11 closed out, a net change of -5 holders.
- The largest Eton Pharmaceutcials buyer in Q4 2021 was Roumell Asset Management, an estimated $2.15M added.
- The largest Eton Pharmaceutcials seller in Q4 2021 was Opaleye Management, an estimated $3.36M sold.
Based on aggregated 13F filings for Q4 2021.